Private Wealth Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$273K Hold
360
– – 0.02% 149
2026
Q2
$224K Sell
360
-1,735
-83% -$1.18M 0.02% 167
2026
Q1
$1.62M Sell
2,095
-175
-8% -$134K 0.12% 78
2025
Q4
$1.75M Buy
+2,270
New +$1.54M 0.12% 74
2016
Q4
– Sell
-500
Closed -$201K – 120
2016
Q3
$201K Buy
+500
New +$201K 0.05% 115

Other funds holding REGN

Private Wealth Partners's REGN Position: Q3 2026 in Review

Private Wealth Partners held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2026 at 360 shares worth $273K. The position accounts for 0.02% of the portfolio, ranked #149.

Private Wealth Partners first reported a position in REGN in Q3 2016 and has held it in 5 quarters since. The position peaked at $1.75M in Q4 2025. 1,432 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Private Wealth Partners held 360 shares of Regeneron Pharmaceuticals worth $273K as of Q3 2026.
  • Private Wealth Partners left its Regeneron Pharmaceuticals share count unchanged in Q3 2026.
  • Regeneron Pharmaceuticals made up 0.02% of Private Wealth Partners's portfolio in Q3 2026, its #149 holding.
  • Private Wealth Partners first reported a position in Regeneron Pharmaceuticals in Q3 2016 and has held it in 5 quarters since.
  • Private Wealth Partners's Regeneron Pharmaceuticals position peaked at $1.75M in Q4 2025.
  • 1,432 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Private Wealth Partners's 13F filing for Q3 2026, filed 22 Oct 2026.